Cp2d
Solution · Intravenous
Warnings and precautions
Warnings and precautions Warnings Not for direct intravenous infusion. Single-use container – discard unused portion. (do not reuse) Do not use unless the solution is clear and no leaks are detected. Precautions Use only with automated red-cell apheresis devices and follow the Operator’s Manual. Refer to the package insert for complete instructions. Storage/handling: Store at 25 °C/77 °F, avoid excessive heat, protect from freezing. Pouch is a moisture barrier; handle to maintain package integrity. Warnings and precautions
Description
Description section ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION (CP2D), 250 mL 0455A-00 Description
Storage
Storage and handling section Store at room temperature (25 °C/77 °F). Avoid excessive heat. Protect from freezing. Storage and handling
Label text from the FDA structured product label by GVS TM INC (revised Nov 6, 2025). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Dextrose, Unspecified Form in 1 product
Cp2d NDC products (1)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 87069-455 | Dextrose, Unspecified Form 4.64 g/100mL Solution | GVS TM INC | NDA |
Frequently asked questions
Who makes Cp2d?
Cp2d is listed by 1 labeler in the FDA NDC directory, including GVS TM INC.